IDENTIV INC (INVE)
US45170X2053 - Common Stock
INVE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 127 industry peers in the Electronic Equipment, Instruments & Components industry. INVE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. INVE is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year INVE has reported negative net income.
In the past year INVE had a positive cash flow from operations.
INVE had negative earnings in 4 of the past 5 years.
In multiple years INVE reported negative operating cash flow during the last 5 years.
1.2 Ratios
INVE has a worse Return On Assets (-6.15%) than 60.32% of its industry peers.
INVE has a Return On Equity of -9.09%. This is in the lower half of the industry: INVE underperforms 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.15% | ||
| ROE | -9.09% | ||
| ROIC | N/A |
ROA(3y)-2.4%
ROA(5y)-3.61%
ROE(3y)-3.52%
ROE(5y)-6.97%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
INVE's Gross Margin of 36.22% is fine compared to the rest of the industry. INVE outperforms 67.46% of its industry peers.
In the last couple of years the Gross Margin of INVE has declined.
The Profit Margin and Operating Margin are not available for INVE so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 36.22% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.24%
GM growth 5Y-3.21%
2. Health
2.1 Basic Checks
INVE does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for INVE has been increased compared to 1 year ago.
The number of shares outstanding for INVE has been increased compared to 5 years ago.
INVE has a worse debt/assets ratio than last year.
2.2 Solvency
INVE has an Altman-Z score of -1.87. This is a bad value and indicates that INVE is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -1.87, INVE is doing worse than 78.57% of the companies in the same industry.
There is no outstanding debt for INVE. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -1.87 |
ROIC/WACCN/A
WACC9.28%
2.3 Liquidity
A Current Ratio of 2.58 indicates that INVE has no problem at all paying its short term obligations.
With a Current ratio value of 2.58, INVE perfoms like the industry average, outperforming 53.97% of the companies in the same industry.
INVE has a Quick Ratio of 1.65. This is a normal value and indicates that INVE is financially healthy and should not expect problems in meeting its short term obligations.
INVE has a Quick ratio (1.65) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.65 |
3. Growth
3.1 Past
INVE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -300.00%.
Looking at the last year, INVE shows a small growth in Revenue. The Revenue has grown by 3.08% in the last year.
Measured over the past years, INVE shows a quite strong growth in Revenue. The Revenue has been growing by 8.30% on average per year.
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2QN/A
Revenue 1Y (TTM)3.08%
Revenue growth 3Y10.23%
Revenue growth 5Y8.3%
Revenue growth Q2Q-0.05%
3.2 Future
INVE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 38.38% yearly.
INVE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.14% yearly.
EPS Next Y39.28%
EPS Next 2Y38.38%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year0.21%
Revenue Next 2Y4.48%
Revenue Next 3Y6.84%
Revenue Next 5Y7.14%
3.3 Evolution
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for INVE. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for INVE. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as INVE's earnings are expected to grow with 38.38% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y38.38%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for INVE!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
IDENTIV INC
NASDAQ:INVE (5/3/2024, 7:00:02 PM)
5
-0.01 (-0.2%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap115.85M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -6.15% | ||
| ROE | -9.09% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 36.22% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover1.06
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 2.58 | ||
| Quick Ratio | 1.65 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-300%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y39.28%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)3.08%
Revenue growth 3Y10.23%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y